The program was based on preferences the organization’s staff radiologists had expressed interest in previously. 

Researchers warn of potential retributions for doing algorithmic medicine wrong in one or more of these ways.

Researchers are optimistic about the treatment's potential, as more options for pancreatic cancer are "urgently needed."